Congenital Diaphragmatic HerniaNCT07397793
Management of Late Presenting Congenital Diaphragmatic Hernia .
A study testing MIS and open surgery repair in people with Congenital Diaphragmatic Hernia, run by Jehad Emam Abdelrahman at 1 site in Egypt.
Trial summary
Diagnosis and different ways of surgical repair of Congenital diaphragmatic hernia Read more about this study
- Who is it for?
- Ages 30 days to 15 years
- Conditions the study is for
- Congenital Diaphragmatic Hernia
- What is being tested?
- MIS and open surgery repair
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2023to 1 Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 days to 15 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Presentation between age of 1 month till 15 yrs
- Underwent surgical repair (open or minimally invasive) at the Pediatric Surgery Department, Sohag University.
- Patient who has complete preoperative and postoperative data
Who cannot join
- 1. Types of diaphragmatic hernia other than CDH 2. Incomplete clinical or follow-up data. 3. Patients who underwent surgical repair outside the Pediatric Surgery Department, Sohag University
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Management of Late Presenting Congenital Diaphragmatic Hernia: A Single Center Experience
Diagnosis and different ways of surgical repair of Congenital diaphragmatic hernia
- Conditions
- Congenital Diaphragmatic Hernia
- Being tested
- MIS and open surgery repair
- Medical subject headings
- Hernias, Diaphragmatic, Congenital
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MIS and open surgery repairProcedure or surgery
Laparoscopic, thoracoscopic and laparotomy surgery
| Study group | Role | What they receive |
|---|---|---|
| Interventional non controlled | Other | Interventional Receives: Procedure: MIS and open surgery repair |
What is being measured
The primary outcome is the main question the study is designed to answer.
Post operative Survival rate
Spontaneous breathing without distress
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2026
- Study start1 Jan 2023
- Primary completion1 Apr 2026 (estimated)
- Study completion1 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Congenital Diaphragmatic HerniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- Jehad Emam Abdelrahman
- Sponsor type
- University, hospital or other
- Collaborators
- Sohag University
- Responsible party
- Sponsor-investigator, Jehad Emam Abdelrahman, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07397793
- Sponsor's protocol ID
- Soh-Med--25-12-8MS
- Status last verified
- Feb 2026
- First submitted
- 6 Jan 2026
- Last updated
- 9 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 9 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Management of Late Presenting Congenital Diaphragmatic Hernia: A Single Center Experience
- ClinicalTrials.gov ID
- NCT07397793
- Acronym / sponsor ID
- Soh-Med--25-12-8MS
- Conditions
- Congenital Diaphragmatic Hernia
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 10 participants (actual)
- Lead sponsor
- Jehad Emam AbdelrahmanUniversity, hospital or other
- Collaborators
- Sohag University
- Study start
- 1 Jan 2023 (actual)
- Primary completion
- 1 Apr 2026 (estimated)
- Study completion
- 1 Jun 2026 (estimated)
- First posted
- 9 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Diagnosis and different ways of surgical repair of Congenital diaphragmatic hernia
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Interventional non controlled | Other | Procedure: MIS and open surgery repairInterventional |
Who may qualify
- Ages
- 30 days to 15 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Presentation between age of 1 month till 15 yrs
- Underwent surgical repair (open or minimally invasive) at the Pediatric Surgery Department, Sohag University.
- Patient who has complete preoperative and postoperative data
Key exclusion criteria (1 listed)
- 1. Types of diaphragmatic hernia other than CDH 2. Incomplete clinical or follow-up data. 3. Patients who underwent surgical repair outside the Pediatric Surgery Department, Sohag University
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MIS and open surgery repairLaparoscopic, thoracoscopic and laparotomy surgery | Procedure or surgery | Interventional non controlled |
Primary outcome
Post operative Survival rate
Time frame: 2 months
Spontaneous breathing without distress
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Feb 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Congenital Diaphragmatic Hernia
Enrolling by invitationObservational study
North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia
Congenital Diaphragmatic Hernia
Active, not recruiting
Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia
Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia
Active, not recruitingPhase 2
Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH
Pulmonary Hypertension of Newborn, Diaphragm Defect
RecruitingPhase 4
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Congenital Diaphragmatic Hernia
Active, not recruiting
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH)
Congenital Diaphragmatic Hernia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing MIS and open surgery repair in people with Congenital Diaphragmatic Hernia, run by Jehad Emam Abdelrahman at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 9 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Post operative Survival rate (time frame: 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2026.